Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
What does HT I stand for?
HT I stands for Hereditary Tyrosinemia Type I
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Hypertension (high blood pressure)
- Hypertropia at Distance (ophthalmology; opposite of hypotropia)
- Hypothermally Treated (EPA)
- Hypotropia At Distance (ophthalmology)
- Transmitter Height
- Tritiated Hydrogen Gas
- Heavy Terminal Modernization (AN/FSC-78B)
- Hazard Tracking and Risk Resolution Log
- Hereditary Tyrosinemia Type 1
- High-Temperature Engine Oil Viscosity Classification
- Hyperthyroidism and Congestive Heart Failure
- Heavy Terminal/Medium Terminal
- Height/Size Radar Set Control
- Hyperthyroidism and Concomitant Unrelated Liver Disease
- Heat Tramsfer 1 (engineering course)
Samples in periodicals archive:
22, 2002 The FDA notified Swedish Orphan International AB based in Stockholm, Sweden that it has granted marketing approval for Orfadin(R) Capsules (nitisinone) an orphan designated product as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of Hereditary Tyrosinemia Type I (HTI).
Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I.